CHRONOS THERAPEUTICS LIMITED
- Legal registered address
- 6-7 Citibase, New Barclay House 234 Botley Road Oxford England OX2 0HP
Latest financial results as of 31 December 2022- Cash in bank
- £58.60k
- Current assets
- £63.75k
- Fixed assets
- £580.73k
- Current creditors
- £9.08k
- Shareholders funds
- £17.82m
View full financial accounts- Cash in bank
- £58.60k
- Current assets
- £63.75k
- Fixed assets
- £580.73k
- Current creditors
- £9.08k
- Shareholders funds
- £17.82m
- Company number
- 06838479
Accounts
Latest annual accounts were to 31 December 2022
Next annual accounts are due by 30 September 2024
Company financial year end is on 31 December 2024
Confirmation statement
Latest confirmation statement statement dated 5 March 2023
Next statement due by 19 March 2024
Nature of business (SIC)
72190 - Other research and experimental development on natural sciences and engineering
Latest company documents
Date | Description |
---|---|
29/09/2329 September 2023 | Total exemption full accounts made up to 2022-12-31 |
18/09/2318 September 2023 | Statement of capital following an allotment of shares on 2023-08-17 |
03/05/233 May 2023 | Appointment of Dr Michael Moore as a director on 2023-04-30 |
03/05/233 May 2023 | Appointment of Dr Shawn David Manning as a director on 2023-04-30 |
03/05/233 May 2023 | Termination of appointment of Christian Gurth Hoyer Millar as a director on 2023-04-30 |
Contact details
Full contact detailsMore Company Information
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company